DURHAM, NC, March 12, 2013 (Press-News.org) MobileSmith, a leading provider of mobile software solutions for enterprise customers, and TVAR Solutions, a value-added reseller of cloud and mobile infrastructure to the US government, announced a strategic partnership to deliver innovative mobile solutions to Federal agencies.
"With TVAR's 20 years of experience delivering cloud IT solutions to the government, MobileSmith can now empower more Federal clients to quickly and cost-effectively build, deploy, and manage secure mobile applications for both iOS and Android devices," said Bob Dieterle, Senior VP and General Manager of MobileSmith.
"Enterprise applications are moving from PC's to mobile devices. MobileSmith accelerates this transition through its ease of use and flexible deployment strategy. Government will be able to deliver services to more Americans in more ways using mobile apps based on MobileSmith," - said Toby Zellers, Vice President of Strategy and Solutions, TVAR Solutions.
MobileSmith is a complete cloud solution for enterprise mobility and a patent-pending SaaS platform that allows creating and deploying custom native mobile apps without writing a line of code. The platform also serves as a back-office for secure management of your organization's entire portfolio of apps; pushing real-time notifications, and easy updating of apps without re-submitting them to the app stores. MobileSmith and TVAR experts provide comprehensive mobile strategy consulting and secure integration of your mobile apps portfolio with your back-end systems.
MobileSmith and TVAR will offer a joint educational webinar: "Agility, Centralization, and Cost Control in Delivering Federal Mobile Applications" on Wednesday, April 10, 2 pm. To register, visit: http://www.mobilesmith.com/webinar-federal-mobile-apps/
MobileSmith is a brand of Smart Online, Inc. (OTCBB: SOLN), a leading provider of cutting-edge mobile software solutions. We empower our customers to get to market quickly with self-built mobile apps that drive business value. Our patents pending MobileSmith platform is an innovative cloud solution that enables organizations to rapidly create, deploy, manage and update custom, native Smartphone apps deliverable across iPhone and Android platforms. With no prior knowledge of software programming, business managers can quickly and affordably take their company mobile.
For more information, visit www.MobileSmith.com
TVAR Solutions is a value-added reseller that can design, deploy, and manage effective infrastructure, from data centers to cloud to mobile devices. Our senior technical advisors, experienced engineers, and proven performance ensure a fully functional, dynamic, and secure enterprise. TVAR Solutions has the people who make Federal IT simple. For more information, visit www.TVARsolutions.com
MobileSmith Partners with TVAR Solutions to Deliver Mobile Solutions to Federal Agencies
TVAR Solutions will help bring MobileSmith's unique cloud technology for quick development, deployment, and management of native smartphone and tablet apps to clients in Federal government.
2013-03-12
ELSE PRESS RELEASES FROM THIS DATE:
CyberlinkASP Completes SSAE 16 SOC 1 Audit Across Datacenter Footprint
2013-03-12
CyberlinkASP, the leader in hosted virtual desktop and private cloud solutions, today announced the completion of the company's annual SSAE 16 SOC 1 audit. CyberlinkASP enlisted an outside accounting firm and subjected itself to a rigorous third party review of all infrastructure, personnel, policies and procedures across its Dallas, Chicago and London facilities.
"This has been a major initiative for us the past few years as more and more firms require documented security policies and procedures relating to IT. We feel it's a must for anyone hosting or managing ...
Laura Wellington: "The Four-Star Diet" Sells Out on Amazon Leading to Invitations From "All-Star" Talk Shows
2013-03-12
No doubt, the media tour for the author of "The Four-Star Diet: Based Upon The Wisdom Of General Colin Powell & Other Ridiculously Brilliant Leaders" has only just begun. Explosive sales on Amazon and similar retailers have made it nearly impossible to get your hands on a print version of the book. With the demand continuing to rise to an already "sell out" crowd, Author Laura J. Wellington has received invitations to appear on numerous "Celebrity, Style, and News" shows from as far away as the UAE. She will begin to make those appearances ...
Rush scientists identify buphenyl as a possible drug for Alzheimer's disease
2013-03-11
(CHICAGO) – Buphenyl, an FDA-approved medication for hyperammonemia, may protect memory and prevent the progression of Alzheimer's disease.
Hyperammonemia is a life-threatening condition that can affect patients at any age. It is caused by abnormal, high levels of ammonia in the blood.
Studies in mice with Alzheimer's disease (AD) have shown that sodium phenylbutyrate, known as Buphenyl, successfully increases factors for neuronal growth and protects learning and memory, according to neurological researchers at the Rush University Medical Center.
Results from ...
Shock teams and ECMO save lives in massive STEMI
2013-03-11
MINNEAPOLIS, MN - March 9, 2013 - The use of extracorporeal membrane oxygenation (ECMO), accompanied by mechanical CPR, in patients with massive myocardial infarctions can lead to unexpected survival. These study findings are being presented March 9 at the American College of Cardiology Scientific Sessions.
ECMO is an advanced technology that functions as a replacement for a critically ill patient's heart and lungs. This is the first report of combined ECMO, mechanical CPR and therapeutic hypothermia (TH) use within a STEMI Network.
"For many patients who present with ...
Niacin therapy shows no benefits, has some harmful effects
2013-03-11
SAN FRANCISCO (March 9, 2013) — A highly anticipated study evaluating a combination of the vitamin niacin with the anti-flushing agent laropiprant finds the therapy provides no benefit to and may even be harmful for patients with vascular disease, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Detailed trial data is presented here for the first time.
Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) is the largest-ever study of niacin, commonly used to raise ...
Drug protects against kidney injury from imaging dye in ACS patients
2013-03-11
SAN FRANCISCO (March 10, 2013) —High doses of a popular cholesterol-lowering drug significantly reduced the rate of acute kidney injury caused by dye used in imaging in acute coronary syndrome patients who underwent a coronary procedure, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. This group of patients is at high risk for kidney damage related to contrast agents used in imaging tests.
Previous studies have demonstrated the kidney-protective value of various statins administered before patients undergo ...
Encouraging early results for redesigned Sapien valve
2013-03-11
SAN FRANCISCO (March 10, 2013) — The new Sapien XT aortic valve showed a non-significantly lower rate of death and strokes at 30 days than the original model, and both valves demonstrated notably better short-term outcomes than seen with the Sapien system in PARTNER I, according to the first results from the PARTNER II study presented today at the American College of Cardiology's 62nd Annual Scientific Session.
PARTNER II is the first randomized clinical trial involving the Sapien XT valve and the only one that compares the new device to the original FDA-approved Sapien ...
New biolimus stent equal to everolimus stent at 1 year
2013-03-11
SAN FRANCISCO (March 10, 2013) — In a match-up of Japan's top drug-releasing stent and a new device featuring a biodegradable coating, the newcomer delivered statistically comparable one-year results, according to data from the NEXT trial presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Drug-eluting stents are structures placed inside narrowed coronary arteries to restore proper blood flow. A polymer coating on these devices slowly releases a drug designed to prevent restenosis—another blockage at the same site—and prevent a second ...
Fewer adverse events with 'double kissing' crush stent than culotte
2013-03-11
SAN FRANCISCO (March 10, 2013) — Patients with a type of coronary lesion linked with poor prognosis fared significantly better with the stent technique known as double kissing crush than with culotte stenting, according to data from the DKCRUSH-III trial presented today at the American College of Cardiology's 62nd Annual Scientific Session.
DKCRUSH-III is the first head-to-head comparison of double kissing (DK) crush and culotte stent techniques in coronary artery disease. The study focused on bifurcation lesions, which involve a main branch and a smaller side branch ...
Cangrelor superior to clopidogrel in CHAMPION PHOENIX trial
2013-03-11
SAN FRANCISCO (March 10, 2013) — The experimental anti-clotting drug cangrelor solidly outperformed commonly used clopidogrel in a large global trial of patients who underwent coronary stent procedures, according to data from the phase III CHAMPION PHOENIX study presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Cangrelor and clopidogrel interfere with the P2Y12 receptor, a platelet-surface protein that helps regulate blood clotting. Currently approved drugs in this class are effective in cutting down ischemic events—blood-flow reductions ...
LAST 30 PRESS RELEASES:
New research boosts future whooping cough vaccines
Mechanistic understanding could enable better fast-charging batteries
No bones about it: new details about skeletal cell aging revealed
UNM scientists discover how nanoparticles of toxic metal used in MRI scans infiltrate human tissue
UMaine research examines best methods for growing Atlantic sea scallops
Medical cannabis could speed recovery, especially at community recovery homes
Study assesses U.S. image amid weakening of democracy
Two scientific researchers to receive 2025 Ralph L. Sacco Scholarships for Brain Health
Researchers improve chemical reaction that underpins products from foods to fuels
Texas Tech to develop semiconductor power devices through $6 million grant
Novel genomic screening tool enables precision reverse-engineering of genetic programming in cells
Hot Schrödinger cat states created
How cells repair their power plants
Oxygen is running low in inland waters—and humans are to blame
ACP’s Best Practice Advice addresses use of cannabis, cannabinoids for chronic noncancer pain
Beyond photorespiration: A systematic approach to unlocking enhanced plant productivity
How a small number of mutations can fuel outbreaks of western equine encephalitis virus
Exposure to wildfire smoke linked with worsening mental health conditions
Research uncovers hidden spread of one of the most common hospital-associated infections
Many older adults send their doctors portal messages, but who pays?
Fine particulate matter from 2020 California wildfires and mental health–related emergency department visits
Gender inequity in institutional leadership roles in US academic medical centers
Pancreatic cells ‘remember’ epigenetic precancerous marks without genetic sequence mutations
Rare combination of ovarian tumors found in one patient
AI-driven clinical recommendations may aid physician decision making to improve quality of care
Artificial intelligence has potential to aid physician decisions during virtual urgent care
ACP and Annals of Internal Medicine present breaking scientific news at ACP’s Internal Medicine Meeting 2025
New study reveals polymers with flawed fillers boost heat transfer in plastics
Signs identified that precede sudden arrhythmic death syndrome in young people
Discovery of bacteria's defence against viruses becomes a piece of the puzzle against resistance
[Press-News.org] MobileSmith Partners with TVAR Solutions to Deliver Mobile Solutions to Federal AgenciesTVAR Solutions will help bring MobileSmith's unique cloud technology for quick development, deployment, and management of native smartphone and tablet apps to clients in Federal government.